Myriad can patent breast cancer genes: US court
Saturday, July 30, 2011 - 03:00
in Mathematics & Economics
A federal appeals court on Friday ruled in favor of Myriad Genetics after a legal battle over whether the US company could keep its patent on genes linked to an inherited form of breast cancer.